Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INTI

Inhibitor Therapeutics, Inc.

CIK 0001042418 · OTC

OTCHealth CarePharmaceutical Preparations
$0.09
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$15.47M
P/E Ratio
-4.68
EPS
-0.02
Dividend Yield
Not covered
52W Position
61%
Beta
-0.52

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-6.04
P/S
Not covered
EV/Revenue
Not covered
ROE
129.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 61%
$0.04$0.12

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$3.30M
Total Assets
$2.51M
Free Cash Flow
–

Recent news